Sagent Pharmaceuticals Inc. (SGNT)
  • Россия
  • Украина

Sagent Pharmaceuticals Inc. (SGNT)

Contact Details

1901 N Roselle Rd Ste 700, Schaumburg, Illinois, USA 60195-3194
(847) 908-1600
1901 N Roselle Rd Ste 700, Schaumburg, Illinois, USA 60195-3194

General Information

Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags. Sagent Pharmaceuticals, Inc. is is based in Schaumburg, Illinois.

Contact Information

Phone(847) 908-1600
Website 1
Thomson Reuters PermID4296253469


NamePositionTotal Annual CompensationYearPercent Change in Compensation
CFO and Executive VP$804,52420149.9%
Executive VP, Other Executive Officer and Secretary$779,06120149.8%
Divisional Executive VP$738,12020148.3%

Government Contracts

Largest Contracts

AgencyProduct or ServiceSigned DateObligation Amount
Department of Veterans AffairsDrugs and BiologicalsOctober 22, 2008$978,722.36
Defense Logistics AgencyDrugs and BiologicalsFebruary 07, 2013$32,344.64
Department of Veterans AffairsDrugs and BiologicalsFebruary 07, 2013$0
Department of Veterans AffairsDrugs and BiologicalsFebruary 12, 2014$0
Centers for Disease ControlDrugs and BiologicalsOctober 14, 2014$0

Corporate Data


  • Pharmaceutical Preparation Manufacturing
  • Drugs and Druggists` Sundries Merchant Wholesalers

SIC Industries

  • Pharmaceutical Preparations
  • Pharmaceuticals

Company Size

Sales Volume$318 million


Ticker SymbolSGNT
ExchangeNASDAQ Global Market
Type of EntityFor Profit Organization
Type of OwnershipNot Tax Exempt Corporate Entity
Federal AwardsReceives Contracts
Other CategorizationsManufacturer of Goods
Year Founded2006


Previous Close12.20
Bid12.04 x 100
Ask12.16 x 100
Day`s Range12.03 - 12.20
52-Week Range11.6 - 26.49
Average Volume (1M)332,708
Forward P/E27.04x
Trailing P/E29.35x
Market Cap.$414.42 Million
Last Dividend Amount0
1y Target Price Est.27.5



Period EndingDec. 31, 2015Sep. 30, 2015Jun. 30, 2015Mar. 31, 2015
Total Revenue83,10775,19977,34582,645
Cost of Revenue60,09650,83758,90460,720
Gross Profit23,01124,36218,44121,925
Research Development10,4887,9235,4195,315
Selling General and Administrative13,99311,40311,41013,125
Depreciation and Amortization----
Other Operating Expenses45,7953,2944213,674
Total Operating Expenses130,37273,45776,15482,834
Other Income/Expenses Net----
Earnings Before Interest and Taxes(47,265)1,7421,191(189)
Interest Expense120188132330
Income Before Tax(47,949)(132)1,575(1,575)
Income Tax Expense(30,012)1,6631,831319
Minority Interest----
Net Income from Continuing Ops(17,937)(1,795)(256)(1,894)
Discontinued Operations----
Extraordinary Items----
Effect of Accounting Changes----
Other Items----
Net Income(17,937)(1,795)(256)(1,894)
Preferred Stock and Other Adjustments----
Net Income Applicable to Common Shares(17,937)(1,795)(256)(1,894)